Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies

Future Med Chem. 2022 Jun;14(11):795-808. doi: 10.4155/fmc-2022-0013. Epub 2022 May 11.

Abstract

Background: Chagas disease is a neglected tropical disease that affects millions of people worldwide and for which no effective treatment is available. Materials & methods: 17 chalcones were synthesized, for which the inhibition of cruzain and trypanocidal activity were investigated. Results: Chalcone C8 showed the highest cruzain inhibitory (IC50 = 0.536 μm) and trypanocidal activity (IC50 = 0.990 μm). Molecular docking studies showed interactions involving Asp161 and the thiophen group interacting with the S2 subsite. Furthermore, quantitative structure-activity relationship (q2 = 0.786; r2 = 0.953) and density functional theory studies were carried out, and a correlation between the lowest unoccupied molecular orbital surface and trypanocidal activity was observed. Conclusion: These results demonstrate that these chalcones are worthwhile hits to be further optimized in Chagas disease drug discovery programs.

Keywords: Chagas disease; QSAR; chalcones; cruzain; molecular docking.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chagas Disease* / drug therapy
  • Chalcone* / pharmacology
  • Chalcones* / pharmacology
  • Cysteine Endopeptidases
  • Humans
  • Ligands
  • Molecular Docking Simulation
  • Protozoan Proteins
  • Structure-Activity Relationship
  • Thiophenes / pharmacology
  • Trypanocidal Agents* / pharmacology
  • Trypanosoma cruzi*

Substances

  • Chalcones
  • Ligands
  • Protozoan Proteins
  • Thiophenes
  • Trypanocidal Agents
  • Chalcone
  • Cysteine Endopeptidases
  • cruzipain